Publication Cover
Journal of Environmental Science and Health, Part C
Environmental Carcinogenesis and Ecotoxicology Reviews
Volume 27, 2009 - Issue 4
286
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

A Critical Review: 2,3,7,8 –Tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD) Effects on Gonad Development in Bivalve Mollusks

&
Pages 226-245 | Received 15 Jul 2009, Accepted 04 Sep 2009, Published online: 30 Nov 2009
 

Abstract

Bivalve mollusks are equally sensitive to 2,3,7,8-tetrachlorodibenzo-p-dioxin's (2,3,7,8-TCDD) effect on gonad development, embryonic development, and epithelial lesion occurrence as higher vertebrates. 2,3,7,8-TCDD alters normal development of reproductive organs and early development in bivalve mollusks at 2 to 20 pg/g wet weight. In both Crassostria virginica and Mya arenaria, 2,3,7,8-TCDD preferentially accumulates into the gonads. The sensitivity of gonad maturation is likely due to disruption of cross-talk between highly conserved steroid, insulin, and metabolic pathways involved in gonad differentiation. The altered gonad development and decreased veliger larval survival can partially explain the lack of self-sustaining bivalve populations in 2,3,7,8-TCDD contaminated estuaries.

ACKNOWLEDGEMENTS

These studies were supported from grants from the NIEHS (ES07148) and NJDEP and NJ Agricultural Experiment Station (NJ01201). We would like to also thank Dr. Tim Kubiak (US Fish and Wildlife Service) for his insightful comments on the manuscript.

This paper was developed from a presentation given at the symposium on “Common Effects Endpoints for Persistent Toxic Substances in Human and Ecological Epidemiology” at the 2007 Society of Environmental Toxicology and Chemistry (SETAC) annual meeting.

Notes

aLesion prevalence taken from Brown (Citation39).

bValues within the table are the percent lesion and the values in () are the number with lesions compared to number of animals with this organ.

aValues in the table mean and standard deviation, and

∗ indicates significant difference from Day 1 value.

bFive animals were sampled at each time point, with the exceptions of Day 21 and 28 for gavage and day 21 for injection where 4 animals were sampled.

aValues in the table are per cent of recovered 2,3,7,8-TCDD equivalents. The values in parenthesis are total recovered 2,3,7,8-TCDD equivalents.

aPlus (+) or negative (−) signs indicate whether the effect was observed in laboratory controlled studies. ND indicates the endpoint was not evaluated. The value in () are doses resulting in significant differences from controls

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.